stockportfolio.pro
Stocks / APGE vs LQDA
APGE vs LQDA
Apogee Therapeutics, Inc. and Liquidia Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Apogee Therapeutics, Inc. (APGE) | Liquidia Corporation (LQDA) | |
|---|---|---|
| Market cap | $6.4B | $6.2B |
| Revenue (latest FY) | $0 | $158.32M |
| Net income (latest FY) | $-255.84M | $-68.92M |
| Revenue growth (5y CAGR) | — | 192.5% |
| Net margin | — | -43.5% |
| Return on equity | -28.3% | -154.0% |
| P/E ratio | — | 410.7 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open APGE — free Open LQDA — freeFrequently asked questions
Which is bigger, APGE or LQDA?
Apogee Therapeutics, Inc. is larger by market capitalization — $6.4B versus $6.2B.
Which grows faster, APGE or LQDA?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.